Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Evansville, Indiana 47714


Purpose:

The purpose of the study is to determine the safety, tolerability and pharmacokinetics of zaleplon delivered by the Staccato thermal aerosol system in healthy volunteers


Criteria:

Inclusion Criteria: - Male and female subjects between the ages of 18 to 55 years, inclusive who are in good general health Exclusion Criteria: - Subjects with a history of allergy or intolerance to zaleplon. Subjects who have any other disease or condition, by history, physical examination, or laboratory abnormalities that in the investigator's opinion, would present undue risk to the subject, or may confound the interpretation of study results.


NCT ID:

NCT00620620


Primary Contact:

Study Director
Daniel A Spyker, MD
Alexza Pharmaceuticals, Inc.


Backup Contact:

N/A


Location Contact:

Evansville, Indiana 47714
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.